Furthermore, our study demonstrated that lnc-ZEB2-19 inhibited HCC progression and LR by specifically binding to RBP TRA2A to affect the stability of RSPH14 mRNA. This evidence concerns the gene ZEB2 and hepatocellular carcinoma.